Cellular, Acellular And Matrix-Like Products (CAMPS) In Pressure Injuries
Rattachement africain : us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Executive summary• The high prevalence and recurrence of pressure injuries (PIs) require new treatment strategies.• The goals of PI treatment and research should be holistic, encompassing quality of life, symptom control, patient-directed goals of care and survival, as well as cure.• Cellular, acellular and matrix-like products (CAMPs) are advanced wound-care tools that promote innate healing processes, such as stimulating fibroblast activity, granulation tissue formation and keratinocyte migration.• CAMPs have been shown to be safe and effective in full-thickness PIs and other hard-to-heal wounds.• Indications for CAMPs should include early application in complex wounds, multiple comorbidities or impaired healing capacity, with or without exposed deep structures.• Patient selection should consider absolute and relative contraindications for CAMPs, as well as differential diagnoses for PIs, such as skin failure and malignant or atypical wounds.• Patients treated with CAMPs require optimisation of offloading, mobility and tissue perfusion, along with addressing nicotine use and polypharmacy, as well as skin protection, nutrition and psychosocial support.• Application of CAMPs must be preceded by wound-bed preparation encompassing tissue debridement, inflammation/infection control, moisture management and optimisation of patient and social factors.• CAMPs should be applied in a clean environment following instructions for use, potentially supported by negative pressure wound therapy.• Use of CAMPs requires ongoing documentation and re-assessment of treatment efficacy and quality of life, with onward referral for osteomyelitis, fistulas or other arterial disease.• CAMPs use should be based in multidisciplinary collaboration and supported by patient and professional education.• The appropriate use of CAMPs in PIs should be applied across all payors and relevant sites of service.• Research on CAMPs in PIs should make wider use of real-world data to support the limited number and narrow scope of randomised control trials.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Cellular, Acellular And Matrix-Like Products (CAMPS) In Pressure Injuries
- Date Crossref
- 01/12/2025
- Éditeur
- Mark Allen Group
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Duke University Adjunct Assistant Professor pays non établi dans la noticeUniversité ou école supérieure
-
Wound Healing Society pays non établi dans la noticeOrganisation à but non lucratif
-
Mount Sinai Hospital pays non établi dans la noticeÉtablissement de santé
-
Methodist Healthcare pays non établi dans la noticeÉtablissement de santé
-
Plastic and Reconstructive Surgeon pays non établi dans la noticeInstitution
-
Plastic Surgeon pays non établi dans la noticeInstitution
-
Physician Assistant and CEO pays non établi dans la noticeInstitution
-
Chief Executive Officer and Founder pays non établi dans la noticeInstitution
-
Mount Sinai West Hospital and the Icahn School of Medicine Chief and Professor of Surgery pays non établi dans la noticeUniversité ou école supérieure
-
Connecticut Clinical Nursing Associates Advanced Practice WOC Nurse pays non établi dans la noticeÉtablissement de santé
-
Director of Pharmacy Consulting/Partner pays non établi dans la noticeInstitution
Adjunct Assistant Professor — Duke University, Wound Healing Society et Mount Sinai Hospital, avec 8 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.